Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 376 results for "Zohydro"

Despite The Sell-Off, Zohydro Is A Falling Knife Too Dangerous...

Summary Zohydro will stay on the market after multiple clear signals from the FDA standing by its approval. The real question is if doctors will prescribe the drug given the crowded space with multiple generics options. I spoke with 2 physicians, ... Seeking Alpha, 1 day ago

158 images for Zohydro

Examiner.com, 1 week ago
Examiner.com, 1 week ago
Examiner.com, 1 week ago
Examiner.com, 2 weeks ago
WCVB.com, 2 weeks ago
WCVB.com, 2 weeks ago
SPi World News, 3 weeks ago
MedPage Today, 2 weeks ago
Business Insider Australia, 1 month ago
Business Insider Australia, 1 month ago
WCVB.com

Judge strikes down part of states efforts to restrict Zohydro

Zohydro, an opioid painkiller made by San Diego-based Zogenix, has put out a pill bottle with a combination lock as one of several measures intended to prevent drug abuse. As the state
 Big News Network1 week ago Judge blocks Massachusetts painkiller restriction  Miami Herald2 weeks ago Zohydro maker's lawyers urge judge to strike down state restrictions on controversial painkiller  Boston Globe1 month ago Zogenix fights new Zohydro ER restrictions  Big News Network1 month ago
[x]  
BusinessWeek

Zohydro details timeframe for new Zohydro version

SAN DIEGO -- The drugmaker Zogenix says a harder-to-abuse version of its powerful painkiller Zohydro could be reviewed by regulators this fall and, if approved, might hit the market early next year. The San Diego company said Wednesday that it ...
 Miami Herald3 weeks ago Zogenix progresses on abuse deterrent versions of Zohydro  Seeking Alpha3 weeks ago How to Sell the Prescription Painkiller Politicians Fear  BusinessWeek4 weeks ago Drugmaker developing abuse-deterrent painkiller  Sify2 months ago
Bidness Etc

Purdue pain pill gets priority review

The FDA grants Priority Review to Purdue for its tamper-resistant pain medication that competes with Zogenix's ( ZGNX ) Zohydro. The agency's review of the company's hydrocodone tablet should take ~six months. Purdue's chronic pain offering is hard ...
 Seeking Alpha2 weeks ago Why Zogeniz (ZGNX) Stock Is Tumbling Today  TheStreet.com2 weeks ago Zogenix Falls On Speculation That Its Drug Will Be Taken Off Market  Bidness Etc2 weeks ago Purdue's Abuse-Resistant Pill Gets FDA Priority Review  Bloomberg2 weeks ago

What If The Figure That Justifies Zohydro's Existence Is Fake?

When the Food and Drug Administration defended its decision to approve Zohydro, a narcotic pill made by Zogenix that, unlike competitors, is not abuse resistant, it fell back on a number from the prestigious Institute of Medicine: 100 million people ...
 Forbes.com4 weeks ago What If The Figure Justifying Zohydro's Existence Is Fake?  Forbes.com4 weeks ago
Business Insider

Chronic pain statistic called exaggerated misleading

When faced with intense criticism for her agency's approval of the powerful narcotic painkiller Zohydro, U.S. Food and Drug Administration Commissioner Margaret Hamburg turned to a
 Big News Network4 weeks ago A Dangerous New Painkiller Is On The Market, And Drug Addicts Are Cheering  Business Insider1 month ago Zohydro Cause for concern  Big News Network1 month ago State Regulators Seek To Impose Controls On New Painkiller  Kaiser Health News1 month ago

Why We Must Not Let Addiction Hysteria Kill Off Zohydro

As a chronic pain patient, a misdirected crusade against opioids has significantly added to my suffering. I'm even afraid to ask my doctor about taking Zohydro. Let's go with the science, not the scare tactics. People with addiction may use ...
 Huffington Post1 month ago
SPi World News

Zogenix (ZGNX) Comments Zohydro ER Decision in Massachusetts

Visit StreetInsider.com at http://www.streetinsider.com/news.php-st=p&id=9647711 for the
 Wall Street Business Network2 weeks ago Zogenix, Inc. Details Timeframe For Possible New Versions Of Zohydro  BioSpace3 weeks ago Zogenix (ZGNX) Updates on Zohydro ER Programs; Expects sNDA Submission in Oct. 2014  TVNewsCheck3 weeks ago Zogenix Provides Update on Development of Abuse Deterrent Formulations of Zohydro(R) ER  Street Sweeper3 weeks ago
[x]  

Zogenix Provides Update on Zohydro(R) ER; Isis Pharma Earns $1M From GSK Hepatitis B Virus Program

Below is a look at some of the headlines for companies that made news in the healthcare sector on July 2, 2014. Zogenix, Inc. (ZGNX) announced an update on its development programs focused on the introduction of abuse deterrent formulations ...
 BioMedReports2 weeks ago Regeneron, Sanofi Offer Positive Results from Phase 2b of Dupilum; Celgene's Drug OTEZLA Fails Phase III Trial Endpoint  BioMedReports1 week ago
Mergers & Acquisitions

Struggling Drug Developer Zogenix Wins Massachusetts Lawsuit

The company won the right to sell painkiller Zohydro in Massachusetts, and plans to develop an abuse-deterrent variation of the drug July 22, 2014 Struggling pharmaceutical company Zogenix Inc. has won the right to sell its Zohydro ER ...
 Mergers & Acquisitions4 hours ago Judge Rules Against Gov. Deval Patrick's Zohydro Ban Again  Big News Network1 week ago Patrick Airs $20m Plan To Combat Opioid Use  Media Awareness Project1 month ago Massachusetts governor unveils plan to tackle opioid drug abuse  Yahoo! Finance1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less